Director DENG Shufen purchased 4,429,337 shares for $7,903,193.57 across two trades; enters position in loss-making company with declining revenue.
Director DENG acquired 4.43M shares in two separate transactions—1,160,542 shares at $2.58 on 2023-05-25 and 3,268,795 shares at $1.50 on 2024-09-10—for a blended average price of $1.78, building a new position of 4,429,337 shares. The timing of these purchases and their substantial size relative to the company's market cap ($31.2M) merit scrutiny, but the fundamental backdrop is critical: REED is unprofitable (net income of $-3.2M in the latest quarter, negative full-year net income) and experiencing revenue contraction (-15.7% annual decline). The second purchase on 2024-09-10 at $1.50 per share occurred while the stock was trading at -64.4% from its 52-week high of $20.88, and the subsequent 30-day and 90-day declines (-18.4% and -24.8% respectively) indicate continued deterioration. These purchases by a director of a substantially impaired company warrant close examination of the insider's rationale and any knowledge of material developments not yet reflected in public filings.